CIK 0001714899 · Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463872213
- Phone
- (650) 866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Chin Peter Scott Chief Medical Officer | Sale | −1,654 | $22.29 | $37K | 204,538 |
| 2026-09-02 | Thornberry Nancy Director | Sale 10b5-1 | −10,824 | $22.85 | $247K | 20,301 |
| 2026-09-02 | Thornberry Nancy Director | Sale 10b5-1 | −615 | $23.74 | $15K | 19,686 |
| 2026-09-01 | Schuth Alexander O. COFO and Secretary | Sale 10b5-1 | −2,768 | $23.44 | $65K | 278,995 |
| 2026-08-11 | Schuth Alexander O. COFO and Secretary | Sale | −2,857 | $25.07 | $72K | 281,763 |
| 2026-01-06 | Schuth Alexander O. COFO and Secretary | Sale | −17,218 | $16.50 | $284K | 282,828 |
| 2026-01-06 | Watts Ryan J. President and CEO | Sale | −35,198 | $16.50 | $581K | 296,833 |
| 2025-08-13 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −806 | $14.64 | $12K | 216,585 |
| 2025-08-12 | Schuth Alexander O. COFO and Secretary | Sale | −2,937 | $13.58 | $40K | 242,346 |
| 2025-08-12 | Ho Carole Chief Medical Officer | Sale 10b5-1 | −2,937 | $13.58 | $40K | 217,391 |
| 2025-07-09 | Watts Ryan J. President and CEO | Sale 10b5-1 | −495,282 | $15.00 | $7.4M | 253,071 |
| 2025-01-07 | Ho Carole Chief Medical Officer | Sale | −2,907 | $20.81 | $60K | 175,673 |
| 2025-01-07 | Schuth Alexander O. COFO and Secretary | Sale | −2,907 | $20.81 | $60K | 244,308 |
| 2025-01-07 | Watts Ryan J. President and CEO | Sale | −7,650 | $20.81 | $159K | 253,071 |
| 2025-01-07 | Krognes Steve E. Director | Sale | −3,339 | $20.81 | $69K | 25,757 |
| 2025-01-06 | Ho Carole Chief Medical Officer | Sale | −12,255 | $20.22 | $248K | 178,580 |
| 2025-01-06 | Schuth Alexander O. COFO and Secretary | Sale | −12,255 | $20.22 | $248K | 247,215 |
| 2025-01-06 | Watts Ryan J. President and CEO | Sale | −29,266 | $20.22 | $592K | 260,721 |
| 2025-01-02 | SATO VICKI L Director | Sale 10b5-1 | −3,080 | $20.91 | $64K | 107,976 |
| 2024-12-31 | Krognes Steve E. Director | Sale 10b5-1 | −30,000 | $20.25 | $608K | 29,096 |
Page 1 of 26 · 520 trades